Kymera Therapeutics Inc
NASDAQ:KYMR
Kymera Therapeutics Inc
NASDAQ:KYMR
Price:
88.54
USD
-1.47%
Market Cap:
$7.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
US |
|
S
|
Saigon Hotel Corp
VN:SGH
|
VN |
|
T
|
Tainan Spinning Co Ltd
TWSE:1440
|
TW |
|
A
|
Aurobindo Pharma Ltd
BSE:524804
|
IN |
|
IQE PLC
LSE:IQE
|
UK |
|
S
|
Solize Corp
TSE:5871
|
JP |
|
Advancer Global Ltd
SGX:43Q
|
SG |
|
O
|
Oriental Interest Bhd
KLSE:OIB
|
MY |
|
Greenbrook TMS Inc
TSX:GTMS
|
CA |
|
Ono Pharmaceutical Co Ltd
TSE:4528
|
JP |
|
S
|
Sescom SA
WSE:SES
|
PL |
|
H
|
Hanil Cement Co Ltd
KRX:300720
|
KR |
|
A
|
Advanced Optoelectronic Technology Inc
TWSE:3437
|
TW |
|
Reconditioned Systems Inc
OTC:AMXX
|
US |
|
K
|
Kyverna Therapeutics Inc
NASDAQ:KYTX
|
US |
|
T
|
TYM Corp
KRX:002900
|
KR |
|
K
|
Kerur Holdings Ltd
TASE:KRUR
|
IL |
|
Y
|
Yonyu Plastics Co Ltd
TWSE:1323
|
TW |
|
Musashi Seimitsu Industry Co Ltd
TSE:7220
|
JP |
|
B
|
Business Engineering Corp
TSE:4828
|
JP |
|
Samick Musical Instruments Co Ltd
KRX:002450
|
KR |
|
Kansai Nerolac Paints Ltd
NSE:KANSAINER
|
IN |
|
A
|
Argenta Silver Corp
OTC:AGAGF
|
CA |
|
C
|
CPM Group Ltd
HKEX:1932
|
HK |
Multiples-Based Value
The
Multiples-Based Value for
Kymera Therapeutics Inc (KYMR)
under the Base Case is
hidden
USD.
Compared with the current market price of 88.54 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KYMR Multiples-Based Value
LOCKED
Multiples Across Competitors
KYMR Competitors Multiples
Kymera Therapeutics Inc Competitors
Kymera Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
7.3B USD | 183.6 | -23.1 | -18.8 | -18.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.7B USD | 6 | 87.6 | 14.5 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.3 | 28.2 | 21.1 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
